← All organizations
Highest phase reached
Phase 3
Acquired by Daiichi Sankyo on Jan 1, 2005
Timeline
1910s
- Jan 1, 1915
Daiichi— Founded
1990s
- Dec 16, 1997
ofloxacin— NDA Secondary Org
2000s
- Jan 1, 2005
Daiichi Sankyo— Acquired By
Drugs by trial phase (6 distinct, 9 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Marketed drugs (1)
Recent trials (10)
- NCT00325390CollaboratorPhase 3Jul 1, 2004
- NCT00080834Study chairPhase 2Feb 1, 2004
- NCT00072228Study chairPhase 1Nov 4, 2003
- NCT00072228Lead sponsorPhase 1Nov 4, 2003
- NCT00061854Study chairPhase 2Apr 1, 2003
- NCT00002137Lead sponsorPhase 1Nov 2, 1999
- NCT00002342Lead sponsorPhase 1Nov 2, 1999
- NCT00002136Lead sponsorPhase 1Nov 2, 1999
- NCT00002138Lead sponsorPhase 1Nov 2, 1999
- NCT00005091Lead sponsorPhase 2Feb 1, 1999
Details
- Founded
- Tokyo, JP Jan 1, 1915
- Last known activity
- Jul 1, 2004